Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane.

Donckier, Julian;Michel, Luc;Berbinschi, A.;De Coster, Patrick;Buysschaert, Martin;et.al.
(1989) Surgery — Vol. 105, n° 5, p. 690-692 (1989)

Files

No attached file found for this publication.

Details

Authors
  • Author
  • Michel, LucUCLouvain
    Author
  • Berbinschi, A.
    Author
  • De Coster, PatrickUCLouvain
    Author
  • De Plaen, JacquesUCLouvain
    Author
  • Ketelslegers, Jean-MarieUCLouvain
    Author
  • Buysschaert, MartinUCLouvain
    Author
Show more
Abstract
A 62-year-old man arrived at our hospital with recurrence of Cushing's syndrome 14 years after successful surgery for adrenocortical carcinoma. Investigations demonstrated recurrence of a large tumor above the right adrenal area; it was found to be inoperable. The patient was treated initially with a new glucocorticoid antagonist, RU 486, and later with the adrenolytic agent mitotane (o,p'DDD). The latter achieved hypoadrenocorticism and a substantial reduction of tumor size. During the initial period, worsening hyperadrenocorticism resulted in a rise of atrial natriuretic factor and an inhibition of renin activity, consistent with an increase of cortisol and plasma volume. Changes in opposite direction were observed after treatment with mitotane.
Affiliations

Citations

Donckier, J., Michel, L., Berbinschi, A., De Coster, P., De Plaen, J., Ketelslegers, J.-M., & Buysschaert, M. (1989). Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane. Surgery, 105(5), 690-692. https://hdl.handle.net/2078.5/88246 (Original work published 1989)